Naloxone in chronic schizophrenic patients: Neuroendocrine and behavioral effects
- 31 July 1982
- journal article
- research article
- Published by Elsevier in Psychiatry Research
- Vol. 7 (1) , 1-7
- https://doi.org/10.1016/0165-1781(82)90047-6
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- The effects of naloxone in chronic schizophreniaAmerican Journal of Psychiatry, 1981
- Failure of naloxone to reduce manic symptomsAmerican Journal of Psychiatry, 1980
- NALOXONE EFFECTS ON MANIC SYMPTOMS AND GROWTH-HORMONE LEVELSThe Lancet, 1978
- PROLACTIN SECRETION, A MEASURABLE CENTRAL EFFECT OF OPIATE-RECEPTOR ANTAGONISTSThe Lancet, 1978
- Intravenous Naloxone Administration in Schizophrenia and Affective IllnessScience, 1977
- Naloxone-induced reversal of schizophrenic hallucinationsJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1977
- Indication of an Antipsychotic Action of the Opiate Antagonist NaloxonePharmacopsychiatry, 1977
- Identification of two related pentapeptides from the brain with potent opiate agonist activityNature, 1975
- Purification and propertiesLife Sciences, 1975
- Stereospecific and Nonspecific Interactions of the Morphine Congener Levorphanol in Subcellular Fractions of Mouse BrainProceedings of the National Academy of Sciences, 1971